Relapsing Multiple Sclerosis (RMS)Symptoms, Doctors, Treatments, Advances & More
Learn About Relapsing Multiple Sclerosis (RMS)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Pavle Repovic is a Neurologist practicing medicine in Seattle, Washington. Dr. Repovic is rated as an Elite provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Neuromyelitis Optica, and Optic Neuritis. Dr. Repovic is board certified in American Board Of Psychiatry And Neurology. Dr. Repovic is currently accepting new patients.
Suburban Geriatrics Inc
Robert Pearlstein is a primary care provider, practicing in Geriatrics and Internal Medicine in Plymouth Meeting, Pennsylvania. Dr. Pearlstein is rated as a Distinguished provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). He is also highly rated in 180 other conditions, according to our data. His clinical expertise encompasses Dementia, Alzheimer's Disease, Painful Swallowing, Gastrostomy, and Endoscopy. Dr. Pearlstein is board certified in . Dr. Pearlstein is currently accepting new patients.
Oklahoma Medical Research Foundation
Gabriel Pardo is a Neurologist practicing medicine in Oklahoma City, Oklahoma. Dr. Pardo is rated as an Elite provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Optic Neuritis, and Neuromyelitis Optica. Dr. Pardo is board certified in Oklahoma State Board Of Medical Licensure & Supervision, Drug Enforcement Administration , American Board Of Psy&Neuro/Neurology , and Oklahoma Bureau Of Narcotics And Dangerous Drugs . Dr. Pardo is currently accepting new patients.
Summary: The purpose of this study is to assess the imaging biomarkers, patient outcomes, safety, tolerability, and treatment satisfaction of ocrelizumab (OCR) combined with recombinant human hyaluronidase (rHuPH20) administered subcutaneously (SC) in participants with relapsing multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS) after switching from another anti-cluster of differenti...
Summary: The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting